drugset

drugset / Trial / NCT02644577

Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder Patients

NCT02644577 ↗

Phase 4 Completed 110 enrolled China Medical University, China

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to test the efficacy of metformin for treatment antipsychotic-induced metabolic syndrome in bipolar disorder patients.

Timeline

Start: 2012-06
Primary completion: 2015-09
Completion: 2015-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Metformin	Small molecule	1000 mg	—

Indications